Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

NSCLC (Non-small Cell Lung Cancer)

Interventions

DIAGNOSTIC_TEST

Blood test

Blood sampling

Trial Locations (1)

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER